Quantum computing at the frontiers of biological sciences
- PMID: 33398186
- PMCID: PMC8254820
- DOI: 10.1038/s41592-020-01004-3
Quantum computing at the frontiers of biological sciences
Abstract
Computing plays a critical role in the biological sciences but faces increasing challenges of scale and complexity. Quantum computing, a computational paradigm exploiting the unique properties of quantum mechanical analogs of classical bits, seeks to address many of these challenges. We discuss the potential for quantum computing to aid in the merging of insights across different areas of biological sciences.
Conflict of interest statement
Competing interests
A.A. serves as a member of the Scientific Advisory Board of, consults for, has received grants from, and holds equity in BlackThorn Therapeutics. G. Sapiro consulted for Apple, Volvo, Restore3D and SIS, and has received speaking fees from Johnson & Johnson. J.T.B. has received consulting fees from BlackThorn Therapeutics, Niraxx Therapeutics, Verily Life Sciences, AbleTo Inc. and Pear Therapeutics, and has received consulting fees and equity from Mindstrong Inc. J.D.M. consults for, has received grants from, and holds equity in BlackThorn Therapeutics. A.W.H. has recently joined the Scientific Advisory Board of Zapata Computing, from which he expects income and equity.
Figures
References
-
- Mohseni M et al. Nature 543, 171–174 (2017). - PubMed
-
- Arute F et al. Nature 574, 505–510 (2019). - PubMed
-
- U.S. House of Representatives. 115th Congress H.R. 6227, U.S. National Quantum Initiative Act (Government Printing Office, 2018).
-
- Monroe C, Raymer MG & Taylor J Science 364, 440–442 (2019). - PubMed
-
- Thew R, Jennewein T & Sasaki M Quantum Sci. Technol 5, 010201 (2019).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
